Drugs / SCT630
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03917628 | May → Nov 2019 | — | Sinocelltech Ltd. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03927352 | Sep 2019 → Dec 2021 | psoriasis | Sinocelltech Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCT630 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03917628 ↗ |
| Route | Subcutaneous | “one subcutaneous (s.c.) injection” NCT03917628 ↗ |